Navigation Links
Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
Date:6/10/2008

Results Suggested Improvements in Several Endpoints for Advair Diskus(R)

Compared to ICS Alone

RESEARCH TRIANGLE PARK, N.C., June 10 /PRNewswire/ -- African American patients with asthma treated with Advair Diskus, a combination of the long-acting beta-agonist (LABA) salmeterol and the inhaled corticosteroid (ICS) fluticasone propionate, had a lower rate of exacerbations when compared with patients who received treatment with the ICS Flovent Diskus(R) (fluticasone propionate inhalation powder) alone, although the difference was not statistically significant. Patients in the Advair group also showed improvements in lung function measures, nighttime awakenings due to asthma, and reductions in daily symptoms and rescue inhaler use compared to Flovent. The data was published in the June 2008 issue of Current Medical Research and Opinion.

This large prospective trial, which followed 475 patients who received either twice-daily Advair Diskus 100/50 (fluticasone propionate and salmeterol inhalation powder) or twice-daily Flovent Diskus 100mcg for a year, was the first prospective study to assess the addition of a LABA to an ICS compared to ICS alone in African Americans with persistent asthma.

In this study, Advair provided important benefits to patients and no increased rate of adverse events compared with Flovent in the African American patient population. The findings of the study also contribute to the body of evidence which has found that salmeterol (a LABA) is not associated with an increase in serious asthma-related events when used with an ICS, but rather provides clinical benefits for patients who require more than ICS treatment alone to control their asthma.

"Uncontrolled asthma is a critical public health issue for African Americans, and this research is reassuring for clinicians whose patients are not controlled on an ICS alone that treatment with Advair helps improve day-to-day asthma control," said
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Calif. , Oct. 1, 2014 /PRNewswire/ ... ), a clinical-stage biopharmaceutical company focused on ... positive results from its 371 patient Phase ... with constipation-predominant irritable bowel syndrome (IBS-C).  Results ... clinically meaningful improvement in IBS-C symptoms for ...
(Date:10/1/2014)... October 1, 2014 Sophia Genetics, ... Sequencing (NGS) data analysis, today launches a unique CFTR ... analysis in a single NGS experiment. The CE-IVD marked ... of variants in a single NGS experiment with clinical ... not been possible to simultaneously analyse all relevant CFTR ...
(Date:9/30/2014)... , Sept. 30, 2014  Wrightington, Wigan ... Allscripts (NASDAQ: MDRX ) are delighted to ... as WWL,s new health information system. The system will ... completely transform the way WWL delivers healthcare in the ... a demonstrated record of on-time and on-budget system implementations ...
Breaking Medicine Technology:Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 4
... /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: ... largest drugstore chain in China based on the number ... will report its third quarter 2010 financial results on ... The Company will host a conference call, to ...
... Tibotec Announced Week 24 Interim Results From Phase... -- HUDDINGE, Sweden, November 1, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:China Nepstar Chain Drugstore to Report Third Quarter 2010 Financial Results on November 17, 2010 2Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 2Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 3Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 4Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 5Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 6Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 7Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 8Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 9Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 10Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 11Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 12Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD 13
(Date:10/1/2014)... California (PRWEB) October 01, 2014 ... to benefit a very special cause. The campaign—“Buy ... support for Paws for Veterans, a nonprofit organization ... while also rescuing shelter dogs that would otherwise ... of featured products will support monthly donations of ...
(Date:10/1/2014)... October 01, 2014 Woodland Hills ... to a group of dental specialists who treat full ... Spain city of Oviedo. Dr. Reshad of the Anacapa ... with clients on two continents, will give a full-day ... full mouth reconstruction. , “These specialists want to improve ...
(Date:10/1/2014)... CA (PRWEB) October 01, 2014 Today ... the Anacapa Dental Art Institute in Oxnard and Woodland ... Bangalore providing full mouth rehabilitation training. , “Speaking to ... of these transformative procedures to get the help and ... rehabilitation may involve repairing previous dental work, providing cosmetic ...
(Date:10/1/2014)... DC (PRWEB) October 01, 2014 Generic ... all retail generics increasing in price in the last ... Services, Inc.’s (AIS) Drug Benefit News (DBN) interviewed a ... trend means for pharmacies and health plans. , ... with rising generic acquisition costs, these cost increases squeeze ...
(Date:10/1/2014)... Madison, Wi (PRWEB) October 01, 2014 ... sales of UP4 WOMEN’S probiotic to The National Network ... month of October. This organization was chosen through nationwide ... UP4’s website and social media outlets. , “We ... to receive a portion of every sale of UP4 ...
Breaking Medicine News(10 mins):Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 2Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 3Health News:UP4 Probiotics Partners with The National Network to End Domestic Violence 2
... 2008 Use of the drug interferon as a ... disease associated with the hepatitis C virus is ineffective, ... nine other institutions have found in a multicenter study. ... (Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis) Trial, appear ...
... Corporation (NYSE: GTS ) today announced that it ... managed care assets of La Cruz,Azul de Puerto Rico, ... Association to transfer the licensing rights to the Blue Cross ... brands in the US Virgin Islands,to the Company and Triple-S, ...
... Available from NetLearning , ... Clifton ... leading provider of integrated e-learning solutions for healthcare training, compliance, ... pleased to announce the latest major release of the Learning ...
... medication used for high blood pressure does not improve ... results from a large, international study. , The ... Medical Center in key leadership positions, appears in this ... Medicine , published today. , The findings are disappointing ...
... finds , , THURSDAY, Dec. 4 (HealthDay News) -- Reactions ... are rare, and young women can tolerate subsequent doses. ... data after more than 380,000 doses of the Gardasil ... in April 2007. , Gardasil protects against four ...
... of Steven Sabock, a 50-year-old man with bipolar disorder who ... psychiatric institution after he choked on medication -- while, ... has focused attention on the crisis in North Carolina,s mental ... tragic, preventable death of Steven Sabock -- which made headlines ...
Cached Medicine News:Health News:HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective 2Health News:Triple-S Management Corporation Signs Letter of Intent to Acquire Managed Care Portfolio of La Cruz Azul de Puerto Rico, Inc. 2Health News:NetLearning Releases Learning Administrator 7.1 for Online Professional Healthcare Training 2Health News:NetLearning Releases Learning Administrator 7.1 for Online Professional Healthcare Training 3Health News:Study finds treatment fails to improve common form of heart failure 2Health News:Study finds treatment fails to improve common form of heart failure 3Health News:Cervical Cancer Vaccine Well Tolerated 2Health News:Tragedy Focuses Spotlight on Crisis in North Carolina Mental Health System 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: